Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma
Interventions:   Drug: Nimotuzumab;   Radiation: Radiation
Sponsor:   Zhejiang Cancer Hospital
Recruiting - verified January 2017

http://ift.tt/2jTZOED